Should You Accumulate Citius Pharmaceuticals Inc (CTXR) Stock Wednesday Morning?

Citius Pharmaceuticals Inc (CTXR) is lower by Wednesday morning, with the stock declining -5.04% in pre-market trading to 1.13. CTXR's short-term technical score of 77 indicates that the stock has traded more bullishly over the last month than 77% of stocks on the market. In the Biotechnology industry, which ranks 109 out of 146 industries, Citius Pharmaceuticals Inc ranks higher than 79% of stocks. Citius Pharmaceuticals Inc has risen 41.67% over the past month, closing at $0.79 on December 28. During this period of time, the stock fell as low as $0.78 and as high as $1.48. CTXR has an average analyst recommendation of Strong Buy. The company has an average price target of $8.00.

CTXR has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on CTXR!

See Full CTXR Report

Citius Pharmaceuticals Inc has a Long-Term Technical rank of 38. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 62% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, CTXR ranks better than 126% of stocks.

Important Dates for Investors in CTXR:

-Citius Pharmaceuticals Inc is set to release earnings on 2/9/2023. Over the last 12 months, the company has reported EPS of $-0.22. -We do not have a set dividend date for Citius Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Citius Pharmaceuticals Inc (CTXR)